J9298
HCPCSInj nivol relatlimab 3mg/1mg
Official HCPCS Level II long descriptor
Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
HCPCS Level II code J9298 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj nivol relatlimab 3mg/1mg
Added to HCPCS: 2022-10-01
Nearby codes in J9
- J9286Inj glofitamab gxbm, 2.5 mg
- J9289Inj nivolumab 2 mg hyaluron
- J9292Inj, pemetrexed dipotassium
- J9293Mitoxantrone hydrochl / 5 mg
- J9294Inj pemetrexed, hospira 10mg
- J9295Injection, necitumumab, 1 mg
- J9296Inj pemetrexed (accord) 10mg
- J9297Inj pemetrexed (sandoz) 10mg
- J9299Injection, nivolumab
- J9301Obinutuzumab inj
- J9302Ofatumumab injection
- J9303Panitumumab injection
- J9304Inj. pemetrexed, 10 mg
- J9305Inj. pemetrexed nos 10mg
- J9306Injection, pertuzumab, 1 mg
- J9307Pralatrexate injection
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.